Single Sales/Supply Contract
GC Biopharma signed a KRW 59.2 billion influenza vaccine supply contract with VaxThera Zona Franca S.A.S. for Colombia on 2026.10.30.
GC Biopharma Corp. Disclosures
006280 · KOSPI · Based on DART filings
Disclosures
3 total · 20 per page
[Amended] Single Sales/Supply Contract
GC Biopharma corrected the amount of its Brazil export supply contract with BLAU Farmaceutica S.A. to KRW 142.1 billion.
· Preliminary EarningsMajor
Q3 operating profit KRW 49.2 billion, up 68.5% from a year earlier
GC Biopharma Corp.'s Q3 consolidated revenue was KRW 522.1 billion, down 14.3% on the year. Operating profit rose 68.5% on the year to KRW 49.2 billion.
Catch the next disclosure fast
Get app alerts for new disclosures from GC Biopharma Corp..